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ATM, the gene that is mutated in ataxia-telangiectasia, is associated with cerebellar degeneration, abnormal pro-
liferation of small blood vessels, and cancer. These clinically important manifestations have stimulated interest in
defining the sequence variation in the ATM gene. Therefore, we undertook a comprehensive survey of sequence
variation in ATM in diverse human populations. The protein-encoding exons of the gene (9,168 bp) and the adjacent
intron and untranslated sequences (14,661 bp) were analyzed in 93 individuals from sevenmajor human populations.
In addition, the coding sequence was analyzed in one chimpanzee, one gorilla, one orangutan, and one Old World
monkey. In human ATM, 88 variant sites were discovered by denaturing high-performance liquid chromatography,
which is 96%–100% sensitive for detection of DNA sequence variation. ATM was compared to 14 other autosomal
genes for nucleotide diversity. The noncoding regions of ATM had diversity values comparable to other genes, but
the coding regions had very low diversity, especially in the last 29% of the protein sequence. A test of the neutral
evolution hypothesis, through use of the Hudson/Kreitman/Aguade´ statistic, revealed that this region of the human
ATM gene was significantly constrained relative to that of the orangutan, the Old World monkey, and the mouse,
but not relative to that of the chimpanzee or the gorilla. ATM displayed extensive linkage disequilibrium, consistent
with suppression of meiotic recombination at this locus. Seven haplotypes were defined. Two haplotypes accounted
for 82% of all chromosomes analyzed in all major populations; two others carrying the same D126E missense
polymorphism accounted for 33% of chromosomes in Africa but were never observed outside of Africa. The high
frequency of this polymorphism may be due either to a population expansion within Africa or to selective pressure.
Introduction
The human ATM gene is an important case study for
mutation analysis. ATM is the gene mutated in the hu-
man recessive disease ataxia-telangiectasia (A-T [MIM
208900]) (Gatti 2001). In addition to the characteristic
ataxia and oculocutanaceous telangiectasias that gave
the disease its name, patients with A-T have a 100-fold
increased risk for cancer (Morrell et al. 1986). Further-
more, obligate heterozygous carriers may have a sixfold
relative risk for cancer, implicating ATM as a possible
tumor-suppressor gene (Morrell et al. 1990). This has
been corroborated by a recent Dutch study showing an
increased risk of breast cancer in ATM heterozygotes
(Broeks et al. 2000). Other breast cancer studies, how-
ever, have been at odds with these results (Vorechovsky
et al. 1996b; FitzGerald et al. 1997; Bay et al. 1998;
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Chen et al. 1998; Bebb et al. 1999; Janin et al. 1999;
Olsen et al. 2001).
The conflicting estimates ofATMmutation frequencies
in patients with breast cancer may be due to the different
patient populations that have been studied or to the in-
sensitivity of available mutation detection methods. In-
deed, there are many technical challenges involved in
analysis of theATM gene. The 13-kbmRNA is assembled
from 66 exons distributed across a genomic region of
150 kb. The coding sequence alone encompasses 9,168
bp (Uziel et al. 1996; Platzer et al. 1997). Gel-based strat-
egies for finding sequence variation in this gene—such as
mismatch cleavage analysis, dideoxy sequencing, the pro-
tein truncation test, or single-strand conformation poly-
morphism analysis—are cumbersome and/or expensive.
As a result, analyses of samples from patients with A-T
detected only 60%–80% of the expected alleles (Gilad
et al. 1996; Telatar et al. 1996; Vorechovsky et al. 1996a;
Concannon and Gatti 1997; Broeks et al. 1998; Ejima
and Sasaki 1998; Sasaki et al. 1998; Castellvı´-Bel et al.
1999; Gatti et al. 1999; Sandoval et al. 1999; Teraoka
et al. 1999).
Denaturing high-performance liquid chromatography
(DHPLC) is a novel, non–gel-based method that is very
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sensitive for detection of DNA sequence variation. De-
tection of sequence variation by DHPLC is based on
differences in retention of perfectly matched homodu-
plexes and heteroduplexes containing one or more mis-
matched base pairs (Oefner and Underhill 1995, 1998).
The choice of temperature during DHPLC is critical for
achieving maximum detection sensitivity, which is
96%–100%. Blinded analyses have shown that DHPLC
is superior to conventional methods (O’Donovan et al.
1998; Choy et al. 1999; Jones et al. 1999; Wagner et
al. 1999b).
This article presents the results of the application of
DHPLC to an analysis of global genetic variation in
ATM. The sequence diversity of human ATM is com-
pared with orthologs in four primate species, as well as
with 14 other human autosomal genes. The implications
of these findings for the identification of neutral se-
quence variation are discussed.
Subjects, Material, and Methods
Subjects and DNA Samples
DNA was obtained from chimpanzee, gorilla, orang-
utan, and macaque (Old World monkey) blood samples,
and from 93 human lymphoblastoid cell lines derived
from individuals enrolled according to approved human
subject protocols. These individuals were believed to
have no obvious genetic disease, although no medical
records are available to confirm this. More than 60%
of the samples came frommales. In detail, the individuals
included 18 fromAfrica (4 Biaka pygmies, 3Mbuti Zaire
pygmies, 4 Lisongo, 1 Omega San, 1 Namibian San, 1
Tsumkwe San, 1 Mandenka, 2 Ethiopian Jews, and 1
Sudanese), 9 from the Middle East (2 Druze, 2 Bedouin,
2 Palestinian, 2 Sephardim, and 1 Iranian), 12 from the
Indian peninsula (1 Pathan, 2 Sindhi, 2 Brushaski, 2
Baluchi, 1 Brahui, 1 Makran, 1 Hazara, 1 Kalash, and
1 Tamil), 20 from Asia (3 Cambodians, 1 Hmong, 1
Atayal, 1 Ami, 8 Han Chinese, 4 Japanese, 1 Korean,
and 1 Yakut), 16 from Europe (2 French, 2 European
Americans from Utah, 1 Amish, 2 Germans, 2 Italian,
1 Dane, 2 Ashkenazi, 1 Adygei, 1 Georgian, 1 Cauca-
sian, and 1 Russian), 8 from Oceania (2 New Guinean,
2 Melanesian, 2 Australian Aborigines, 1 Micronesian,
and 1 Samoan), and 10 American Indians (1 Karitiana,
1 Surui, 2 Mayans, 2 Colombian Indians, 1 Quechua,
1 Muskogee, 1 Pima, and 1 Navaho).
PCR primers designed from the humanATM sequence
were used to amplify the homologous regions of ATM
for sequencing in four primate species: chimpanzee, go-
rilla, orangutan, and macaque monkey. The orangutan
and macaque samples were obtained from Coriell Cell
Repositories. Some exons from the primate species did
not readily amplify with the human primers. The pro-
portion of the ATM coding sequence amplified in each
species is listed in the Results section. The chimpanzee
sample was also analyzed by DHPLC for all ATM exon
regions except exons 14 and 35. The PCR products from
the chimpanzee template were sequenced even when the
DHPLC profile was homozygous.
DNA Extraction
Total genomic DNA was prepared through use of a
QIAamp DNA Mini Kit (Qiagen). DNA samples were
diluted with TE buffer (10 mM Tris, 1 mM EDTA) to
a working concentration of 30–50 ng/ml and were stored
in an 96-well microtiter plate format. For PCR, 2 ml of
the DNA stocks were dispensed into 96-well microtiter
plates by a Hydra96 robot (Robbins Scientific) and were
dried for 10–20 min by a SpeedVac Concentrator (Mod-
el SC210A or AES1010, Savant Instruments).
PCR Conditions
All 62 coding exons (9,168 bp) of ATM, as well as
14,661 bp of noncoding exon sequence (9,110 bp of
intron sequence adjacent to coding exons and 5,551
bp of 5′ and 3′ noncoding exon sequence), were PCR
amplified from genomic DNA through use of the 71
primer pairs listed in table 1. All primers were com-
plementary to intron sequences near the exon bound-
aries except those in the 5′ and 3′ untranslated sequence
that were amplified in overlapping segments. The exons
were numbered according to established convention
(Platzer et al. 1997). PCR primers used for amplifica-
tion of regions containing ATM exons 10, 12, 19, 20,
23–37, 40–44, 55, 56, 57, 58, and 63 have been pub-
lished elsewhere (Hacia et al. 1998). Primers for the
remaining exon regions were selected from the pub-
lished genomic sequence for ATM (GenBank accession
number HSU82828), using the computer program
Oligo 4.0 or Oligo 6.4 (Molecular Biology Insights).
Amplicons were optimized for DHPLC by the choice
of primer pairs that minimized the temperature differ-
ence in melting domains across the region and that
maximized the length screened, to as many as 550 bp.
The exons were amplified individually, except in four
cases, in which two nearby exons could be amplified
together.
PCR amplification was performedwithAmpliTaqGold
(PE Biosystems) in 30–50-ml reactions, using a Touch-
down PCR protocol that made it possible to use the same
conditions for every amplicon. The samples were then
taken directly from PCR to a denature/reanneal protocol,
which involves heating to 95C then slowly cooling to
65C over 30 min, using the PCR System 9700 thermo-
cycler (PE Biosystems). Touchdown PCR conditions were
1 cycle of 95C for 10 min; followed by 14 cycles of 95C
Table 1
Primers and DHPLC Conditions for Mutational Analysis of Human ATM
ATM
EXON
PRIMER
LENGTH OF SEQUENCE
(bp)
DHPLC
CONDITIONS
Forward
(5′r3′)
Reverse
(5′r3′) Coding
Non-
codinga Total
Temper-
ature
(C)
Gradient
(% of
Buffer B)
Promotor GCCCAGAACCTCCGAATGACG CGACTTAGCGTTTGCGGCTCG 0 493 535 63 59–64
1A AATGTTTTGGGGCAGTGTTT AGGAAAGATGGAGTGAGGAGAG 0 370 412 63 58–63
1B GACTCCTCCCTCTCCTCACTC CCATCTGGAAGGCTTCTACC 0 515 556 60 60–65
1B, 2 TGCAAACTCAGCCTGAGACT CATGCCATTCTTTTCTAGTGC 0 491 532 59 54–60
3 TGAACCTTGAGTGGAACCTA CTCTGAGGAAACAAAAACACA 0 294 335 57 53–58
3 TTGGCACCAGTTAGTTCAGA CAGAAGATGCTCATTCACTGA 0 260 300 54 55–60
4, 5 TACACATTTTTTCACACCTCTTTC AGGCATAATGATATATAGGAAGCA 185 263 496 50, 55 60–66, 58–64
6 ATTGGTCTTGTAGGAGTTAGGC AAAAACTCACGCGACAGTAATC 146 202 392 54 58–64
7 TTGCCAATTTCTTCTCTACAAAAG TTAAGGGTCAGTTCGATAACCATA 165 241 454 55 54–60
8 CTTTTTCTGTATGGGATTATGGA TTCTGTTATGATGGATCAATGTTT 166 177 390 50, 55 57–63, 51–56
9 CAGCATACCACTTCATAACTG TCATATCCTCCTAAAGAACAC 239 131 412 54 56–61
10 CTAGCAGTGTAAACAGAGTA ATAGGCTTTTTGTGAGAACA 164 121 325 54 55–60
11 GCAACAACAGCGAAACTCTG GAATGAGAAAATGGTAACACTT 170 139 350 53, 56 56–61, 53–58
12 TGTGATGGAATAGTTTTCAA AGTAACAAACTATGAAAATGA 372 98 511 57 56–62
13 CAATAGCTTGCTTTTCACAAT TGGCATCAAATAAGTGGAGAG 195 92 335 57 54–59
14 GATGAAAGCAATTTTAATCTAGGA TCAGTTTTTCTCATTGGCACTT 96 340 482 54 56–62
15 CATATAAGGCAAAGCATTAG AGTTTACCAAAGTTGAATCATA 226 72 340 55 53–59
16 GTTGTTTTTAGAGCTATCCAGGA CTGCATCATGTACCCCAGAAC 126 332 502 53, 57 58–63, 55–61
17 CGTGGAACTTCTAAAAACATTTC CAAAACAGTAACACCAACCAGT 126 346 517 54, 59 59–65, 54–59
18 AGCTCACTTATCTTTAGGGTCAA GGCCTTAATTTCCACATTTGT 90 329 463 54 57–62
19 CTCCTGCAAGAAGCCATCT AAGAAATCCCAAGTAGTAAAT 172 38 250 57 53–58
20 CTTTTTTTTGTGAAGAGGAGGA TTTCAATTCTTCAAAGACACCA 200 156 400 51, 58 58–64, 52–58
21 TTTTTCCCTCCTACCATCTT CTTAACAGAACACATCAGTTATT 83 78 173 55 50–55
22 TAAAATAACTGATGTGTTCTGTT CAAAACTTGCATTCGTATC 156 150 286 56 54–60
23, 24 TAGCACAGAAAGACATATTGGAAG TGTAAGACATTCTACTGCCATCTG 207 236 491 55 56–61
25 AGCTGCTGGTCTGAACCTCTTTA TTGCTATGATTTGACCCATTGTG 118 324 488 54, 57 56–60, 51–57
26 TGGAGTTCAGTTGGGATTTTA TTCACAGTGACCTAAGGAAGC 174 87 303 51, 55 58–64, 56–61
27 CTTAACACATTGACTTTTTGG GTATGTGTGTTGCTGGTGAG 170 78 288 54 54–59
28 TGCTGATGGTATTAAAACAGTTT GGTTGGCTATGCTAGATAATGAT 247 192 485 51, 56 58–64, 54–60
29 GAGCTGTCTTGACGTTCACAG TTAAAAAGAGTGATGTCTATAA 116 131 290 53, 57 56–61, 51–57
30 TTAAAACGATGACTGTATT GAAGGAATGTTCTATTATTA 127 40 207 56 51–56
31 CTGAAAATTAAATAAATTGGCAAT AAAACAGGAAGAACAGGATAGAAA 200 227 475 54 56–61
32 CTTACTGGTTGTTGTTGTTTT CCATTTTGAAGATGAGTCAG 175 26 241 57 52–58
33 GTTTTGTTGGCTTACTTTA GAGCATTACAGATTTTTGAA 165 99 304 53 53–59
34 GTGTTAAAAGCAAGTTACATT AAGAAACAGGTAGAAATAGC 133 33 207 56 50–55
35 GCAATTATAAACAAAAAGTGT TATATGTGATCCGCAGTTGAC 96 78 215 57 53–58
36 CAGCATTATAGTTTTGAAAT GTGTGAAGTATCATTCTCCA 172 114 326 55 54–60
37 TGGTGTACTTGATAGGCATTT GACCCACAGCAAACAGAACTG 142 63 245 57 52–57
38 AACCTAATTTTTCTGCTGCCTAA GAGTGGGGGTGATATTATGTGA 177 279 501 55 58–64
39 GCAGTATGTTGAGTTTATGGCA GCAACTGTTGGCAACTTTTAT 178 260 481 53, 57 58–64, 54–60
40 ATAAACAAGAAGGAAGAAGGT ACGTAAGAAGCAACACTCATT 88 56 184 58 51–56
41 CAACATGCTTTTATTTTGATA TATATACCCTTATTGAGACAA 156 90 288 55 53–59
42 TCTCATTAAAAGAGGTGTTCT TGAGATAAATACTGTCATAAA 88 34 164 56 (49) 51–57
43, 44 AAATTTGCTAAATTTATAGACCGA AGTGATGGCTTTACCAAATCTGG 192 152 391 57 55–60
45 TTTGCTGTTTTTTTCTCTGGT CAGTTGTTGTTTAGAATGAGGAGA 149 91 285 56 53–59
46 ATTTTGTCCTTTGGTGAAGCTA CAAGTTTTCAGAAAAGAAGCCA 105 109 258 53 55–60
47 GCAAAGCCTATGATGAGAACTC CAGAAAAGCTGCACTTTAGGAT 120 103 267 53, 57 55–61, 50–55
48 TCTTGTCACTACAAAAGTTCCTTT TCTTTTTCCCTCAGGCTTTC 235 165 444 51, 56 61–67, 56–61
49 CCTCAATGAATGGTAGTTGCT GTAAAACACTAATCCAGCCAATA 168 87 299 53, 58 57–63, 51–56
50 CCAAAGCAGATGAGGAAAAAC TCTTGATGAAAAGATGAAGCATAT 114 165 325 56 54–59
51 GTGTATTACCTTAATTTGAGTG CCAAAAGACCAAGATAATCT 218 191 451 55 61–67
52 TCCTTAGAAGTTTGCTTTTTTC CTGGACCAAGTGCTAGGAATA 208 199 450 57 57–62
53 CTAGAGTACCCATTAGAAAGACCT GTGTATGCCTGCATGTGTGA 114 346 504 50, 55 64–69, 59–64
(continued)
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Table 1 (continued)
Primers and DHPLC Conditions for Mutational Analysis of Human ATM
ATM
EXON
PRIMER
LENGTH OF SEQUENCE
(bp)
DHPLC
CONDITIONS
Forward
(5′r3′)
Reverse
(5′r3′) Coding
Non-
codinga Total
Temper-
ature
(C)
Gradient
(% of
Buffer B)
54 CTCTGCCTTTTTCTCACACAT CCTTGAACCGATTTTAGATGG 159 218 419 56 54–60
55 GGGTAGTTCCTTATGTAATGT GTAACACAGCAAGAAAGTAACGT 139 42 225 56 50–56
56 GACCTTCAATGCTGTTCCTCAGT AGGTTGAAACATATGAAATTTGCC 83 135 265 54 52–58
57 ACCCGGCCTAAAGTTGTAGT AATGGAGAAAAGCCTGGTTC 141 278 459 57 53–59
58 TTTGCTATTCTCAGATGACTCT ATGTTtTTGGTGAACTAACAGAAG 117 69 232 56 51–56
59 GCTGAATGATCATCAAATGCTCT ATAATATCTGACAGCTGTCAGCT 150 99 295 52, 57 60–66, 54–60
60 TTTATTGCCCCTATATCTGTCAT AAAAAGTGCTGAATCAAACAAA 166 134 345 55 56–61
61 CAACATGGCCGGTTATGC CACTCAGTACCCCAGGCAGA 87 305 430 54 57–63
62 GTGGTTTCTTGCCTTTGTAAAGTT AATCCTCCCACTTCAGCCTCTT 115 162 323 58 58–63
63 TAGGCTCAGCATACTACACAT GACGAGATACACAGTCTACCT 64 117 223 55 51–56
64, 65 GGCTTATTTGTATGATACTGGTTC CTAAAGGCTGAATGAAAGGGTA 318 191 555 53, 58 60–65, 55–61
65 TACCCTTTCATTCAGCCTTTAG TTTTTTTTTTGAGATGGAGTTTC 0 470 515 56, 61 64–69, 59–64
65 TCTCAAAAAAAAAAAAAAAAAACA TGGGAATATGACATAAACAGACA 0 538 586 53 60–65
65 AGGCTTTATCTATGGGAATCTT AGAGGTGAATATGTGAGCTGAT 0 370 414 59 56–61
65 CTCATTTTTGACCGTAAGGA AAGTTCTGGAGATTGGTTTTAG 0 411 453 56 59–64
65 CCTCCCCTAAAACCAATCT AGTTATTTCTCCTAGGCTTGTG 0 417 459 54 58–63
65 ATGGCTTTGAAAAGTTTATCA TAGGGTGGGAAAGCTATTATC 0 579 621 56 56–61
65 ATGAAAACCAAATAGTGAAGC TGGCACACAGAACACACAA 0 467 508 55 59–64
a Noncoding length does not include primer sequence.
for 20 s, 63C for 1 min (decreasing by 0.5C/cycle), and
72C for 1 min; 19 cycles of 95C for 20 s, 56C for 45
s, and 72C for 45 s; and 1 cycle of 72C for 7 min. PCR
was carried out in a separate room, and only filtered pi-
pette tips were used. To monitor for the presence of con-
tamination, every plate had a negative control containing
no added DNA.
DHPLC
The optimum temperature of analysis was determined,
for each amplicon, by the DHPLC Melt program (Jones
et al. 1999), available at the DNA Variation GroupWeb
site. All ATM amplicons were run within 1C of the
recommended temperature, as indicated in table 1. If the
program recommended two temperatures, then both
temperatures were used, except in nine cases (exons 12,
15, 35, 41, 42, 43/44, 51, 58, and 60), for which only
the highest temperature was used.
The chromatographic profiles of all but two ATM
polymorphisms were clearly distinct from that of a ho-
mozygous control. Two sequence variants of ATM pro-
duced only a subtly different chromatographic profile
when analyzed at the recommended DHPLC conditions.
For the first one, 5185CrG, the normal allele had one
leading shoulder, and the heterozygous allele had two
leading shoulders. For the second one, IVS62-55TrC,
the normal allele had a slightly broadened peak, and the
heterozygous allele had a leading shoulder on that peak.
Microtiter plates containing completed PCR reactions
were loaded into an autosampler for automated
DHPLC, using either the Transgenomic WAVE System
or the Varian Helix System. Injection volume was 10–12
ml. In both systems, the DNASep column was used. The
samples were run using the temperature and gradient
conditions listed in table 1. The gradient was generated
by increasing the concentration of buffer B (0.1M trieth-
ylamine acetate, 25% acetonitrile) relative to buffer A
(0.1M triethylamine acetate). The numbers (X–Y) listed
in the “DHPLC Gradient” column in table 1 represent
shorthand notation for the gradient (expressed as a per-
centage of buffer b): 50%–X% in 0.5 min; X%–Y% in
3.0 min; Y%–95% in 0.1 min; 95% for 0.5 min;
95%–50% in 0.1 min; 50% for 0.8 min. The acetonitrile
gradient was adjusted so that the homoduplex signal
from the reference sample eluted from the column at a
retention time of 2.8–3.4 min. These conditions were
found empirically to maximize the resolution of heter-
oduplex and homoduplex signals. Each sample run took
6 min.
All samples were completely analyzed for the entire
region sampled, except those from two Africans: a Man-
denka, for whom insufficient amounts of DNA were
available, and a Sudanese, who replaced another African
after the study was already underway. Sequence variants
observed in both samples are listed in the Results section,
but the Mandenka could not be genotyped and therefore
was not included in the haplotype analysis.
Genotypes of the 17 most frequent polymorphisms
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were determined by DHPLC. Samples that were ho-
mozygous for either allele had only one peak and would
be indistinguishable from one another without a refer-
ence. Therefore, the amplicons from the homozygotes
were mixed with a sample of known genotype, through
use of a protocol originally established for the Y chro-
mosome (Underhill et al. 1997).
Direct DNA Sequencing
The chemical nature and location of the mismatches
underlying the different heteroduplex profiles detected
were determined by direct DNA sequencing. For this
purpose, excess oligonucleotide primers and dinucleo-
tide triphosphates were removed by treating 10 ml of
each PCR reaction with 1 unit each of exonuclease I and
shrimp alkaline phosphatase (Amersham/Life Technol-
ogies) for 30 min at 37C and for 15 min at 80C. The
PCR products were then sequenced with the BigDye
Deoxy Terminator cycle sequencing kit (PE Biosystems),
according to the manufacturer’s instructions. After solid-
phase extraction with Sephadex G-50 (Amersham Phar-
macia), the sequencing reactions were analyzed with a
PE Biosystems 377A sequencer.
Statistical Analysis
Nucleotide diversity was calculated as estimated nu-
cleotide diversity (p), if complete genotypes were avail-
able (AMPD1, ATM, BRCA1, DFFRY, MMP1, MMP3,
MMP12, SMCY, andUTY), or as average heterozygosity
(v), if only heterozygotes were known (ABCB1, BRCA2,
CACNA1A, COX2, FBN1, IL4, RB1, WRN, and
XRCC1). The value of v is very close to that of p if
Hardy-Weinberg equilibrium is satisfied. In a sample of
n chromosomes, p was calculated from the equation
, where pij is the number of nucleotide dif-pp  p /n!i j ij c
ferences between the ith and jth DNA sequences and
(Nei 1987). Average heterozygosity pern p n(n 1)/2c
site was calculated by dividing the sum of the relative
frequencies of heterozygotes per polymorphic site by the
total number of base pairs screened. Tajima’sD statistic
(Tajima 1989b) was calculated by the equation
d
Dp ,
ˆ ( )V d
where , S is the number of segregatingn1dp p S/ 1/iip1
nucleotides and is an estimator of the variance ofˆV (d)
d. The value of D is expected to be 0 for selectively
neutral variants and infinite sites in a constant popula-
tion. A greater-than-expected number of rare variants
would result in a negative value of D, indicating either
purifying selection or population expansion (Tajima
1989a). The Hudson/Kreitman/Aguade´ (HKA) test
(Hudson et al. 1987) was applied, using a computer
program obtained from M. Nachman, to further inves-
tigate the possibility of selection acting on theATM gene.
The HKA test compares levels of intraspecific polymor-
phisms at different loci and interspecific sequence dif-
ferences at these loci, with expectations—under a neutral
evolution model—of an infinite number of sites. A neu-
tral model predicts that the ratio between levels of in-
traspecific polymorphism and interspecies divergence
should be the same for different genes, since both are a
function of the neutral mutation rate. Selection, in con-
trast, can lead to an uncoupling of levels of polymor-
phism and divergence.
Inference of Haplotypes from Simple Sequence
Polymorphisms (SSPs)
Haplotypes were inferred by a maximum-parsimony
approach, as described elsewhere (Jin et al. 1999), for
each of the 91 individuals for whom complete genotyp-
ing data had been obtained at the 17 sites that were
heterozygous in 13 individuals (fig. 3). Polymorphic sites
from a group of haplotypes or sequences were consid-
ered congruent if they could be accommodated by the
same phylogenetic topology. Polymorphic sites were
considered recurrent if linkage to flanking markers could
not be explained by a single recombination event. In the
construction of the tree by maximum parsimony, hap-
lotypes of each individual with multiple polymorphisms
were inferred, assuming the smallest number of muta-
tional steps and that any incongruence between loci in-
dicates recombination or recurrent mutation.
Of the 17 common polymorphic sites, 10 could be
accommodated by the same phylogenetic topology,
whereas 5 sites were found to be incongruent because
of recurrent mutation, or reversion. Site IVS437insAA
was recurrent in samples from all the population groups.
Site IVS22-77TrC was recurrent in three samples, one
fromAmerica and two fromAsia; site IVS25-12insAwas
recurrent in Africa only. Site IVS48-69insATTwas found
to be recurrent in one African sample and in two Amer-
ican samples, and site IVS61104CrT (part of a CpG
motif) was recurrent in two samples, one from Africa
and one from the Middle East. All recurrent sites can
be explained by common mutation mechanisms.
Comparison of ATM with Other Genes
DHPLC analysis of 14 autosomal and 3 Y-chromo-
some genes was performed in a way similar to that de-
scribed forATM, using gene-specific PCR products span-
ning the coding and flanking intron sequences for each
gene. The human gene names are standard for the online
resource LocusLink. The GenBank accession num-
bers are as follows—ABCB1 (also called “MDR1”):
AC002457; AMPD1: M60092; BRCA1: U14680;
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BRCA2: U43746; CACNA1A (also called “EA2”):
AF004884; COX2 (also called “PTGS2”): U04636;
FBN1: L13923; IL4: M23442; MMP1 (also called
“MTE”), MMP3 (collagenase), and MMP12 (strome-
lysin): U78045; RB1: M15400; WRN: AF091214; and
XRCC1: M36089. The mRNA and amino acid se-
quences of mouse Atm was obtained from GenBank (ac-
cession number MMU43678).
Results
SSPs
Variation in the human ATM gene was analyzed by
DHPLC, which detects DNA sequence variation with a
sensitivity of 96%–100% (Choy et al. 1999; Jones et al.
1999; Wagner et al. 1999b). The sensitivity of DHPLC
in this study was confirmed in our laboratory by a
blinded analysis of 73 known A-T patient samples, in
which 99 of 100 previously identified variants in ATM
were detected (data not shown).
Table 2 lists the 88 variant sites found in 93 human
representatives from seven continental regions. Transi-
tions accounted for 59% of all sequence variants. Trans-
versions, deletions, and insertions accounted for 32%,
3.4%, and 5.7% of sequence variants, respectively. Se-
quence variation occurred in 26 of 9,168 nucleotides (1
in 353) in the coding regions, and in 62 of 14,661 nu-
cleotides (1 in 236) in the noncoding regions. Of the 26
polymorphisms located in exons, 8 were silent, and 18
were missense polymorphisms. Of the 18 missense poly-
morphisms, 9 resulted in nonconservative amino acid
changes, but their functional significance remains un-
certain. With two exceptions, namely the conservative
amino acid changes D126E and D1853N, all missense
polymorphisms were observed only once or twice in the
93 individuals tested. The global distribution of D126E
was unusually high in Africa.
Of the 88 polymorphisms listed in table 2, 53 (60%)
were observed only once, and they were found in both
the noncoding and coding regions. The frequency of sin-
gletons is very similar to that observed in BRCA2,where
they constituted 59% of all sites (Wagner et al. 1999b).
However, it was quite different from the Werner syn-
drome gene (Passarino et al. 2001), in which only 33%
of the 58 polymorphisms identified in an identical set of
individuals were singletons. Another 18 polymorphic
sites in ATM were observed two or three times in the
screening set. The remaining 17 polymorphisms were
observed in four or more individuals.
Consistent with the oldest human populations existing
in Africa (Stringer and Andrews 1988; Tishkoff et al.
1998; Underhill et al. 2000), 61% (54/88) of the poly-
morphisms were found there. Not surprisingly, 17 of
those polymorphisms were also detected in other con-
tinents. (The derived allele of IVS17-114CrGwas found
a second time, in Oceania, as a homozygote.)
Haplotype Analysis
Haplotypes for each individual were inferred by a
maximum-parsimony approach, using the genotype data
of 17 polymorphic sites that had been observed to be
heterozygous in four or more individuals. The genotypes
of each individual are diagramed in figure 1. Ten of the
sites were in complete linkage disequilibrium over 1133
kb.
Seven haplotypes, H1–H7, could be inferred, and their
phylogenetic relationship is depicted in figure 2. Two
clusters of haplotypes, H2–H3 and H4–H7, could be
distinguished. H1 was hypothesized to be the oldest hap-
lotype in the phylogeny, since it was identical to the
chimpanzee haplotype. Of 10 sites defining the haplo-
types, only two single–base-pair changes resulted in
amino acid changes, which are indicated in parentheses.
Arrows indicate the number and direction of sequence
changes. Several intermediate haplotypes between H2
and H3 and between H4 and H5 were not observed in
the present study, because of either the relatively small
size of the screening set or their disappearance due to
random genetic drift or selection.
The color coding in figure 2 indicates the geographic
distribution, and the areas of the circles are proportional
to the frequencies of the seven haplotypes. Strikingly,
two haplotypes, H2 and H4, were found in every region
of the world, accounting for 82% of the chromosomes
observed.
Like nucleotide diversity, haplotype diversity was
greatest in Africa, where five out of seven haplotypes
were found. This is consistent with many other obser-
vations leading to the hypothesis of an African origin of
modern humans. Of the two haplotypes not found in
Africa, one is a singleton (H5), whereas the other (H3)
was observed at relatively low frequencies on all con-
tinents. H1 was only observed in Africa and Oceania.
The African haplotypes H6 and H7, which share the
missense polymorphism D126E, were particularly in-
triguing. These two haplotypes were very common in
Africa but were not found elsewhere in the world. H6
was only found in the rain forests of central Africa, but
H7 was found in climatically diverse regions all across
Africa. H5 also shared D126E and was found only once,
in an individual from the Makran coast of Pakistan; this
haplotype may be associated with a relatively recent in-
troduction from Africa, through trade relationships.
The geographic distribution of D126E was unusual
when compared to distributions of missense polymor-
phisms in the 14 other autosomal genes reviewed in this
study. All except one of the missense polymorphisms in
these genes were randomly distributed, with equal per-
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Figure 1 Genotype data for 17 polymorphic sites in ATM, obtained for 91 representatives from seven major human populations. An
asterisk (*) indicates that the polymorphism was not included in the haplotype analysis, because of recombination or recurrent mutation. White
circles represent the homozygous ancestral allele, black circles the homozygous derived allele, and gray circles the heterozygotes. The nucleotide
positions of the 17 polymorphic sites, in relation to the cDNA sequence (GenBank accession number U82828), are given at the top.
centages in African and non-African populations. The
exception was a missense polymorphism in MDR1
(A259S) that was heterozygous in 49% of non-Africans
but was never seen in Africans.
The non-African haplotype, H3, was distinguished by
the missense polymorphism D1853N. H3 was found on
an average of 8% of chromosomes everywhere except
in Africa. Its distribution and distinct absence in Africa
is similar to that observed for M9 on the Y chromosome
(Underhill et al. 1997).
Comparison of ATM Orthologs
Figure 3 shows a comparison of the ATM coding se-
quence in human and chimpanzee. Figure 3A shows the
distribution of differences, along the ATM protein, be-
tween human and chimpanzee, as well as polymor-
phisms within the single chimpanzee individual. There
were 32 coding-sequence differences between human
and chimpanzee. Of the single–base-pair changes, 9were
polymorphic in the single chimpanzee sample, and the
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Figure 2 Phylogenetic relationship among seven ATM haplo-
types. A chimpanzee sequence was used to determine the root of the
phylogeny (H1). The circles each represent one haplotype, the area of
the circle is proportional to the number of chromosomes observed
with that haplotype, and the colors represent seven distinct geographic
regions. The number of arrows indicates the number of changes re-
quired to generate the next related haplotype.Missense polymorphisms
are indicated in parentheses. The number of observations are sum-
marized in the table at the bottom of the figure. The haplotypes were
defined by the nine congruent sites observed in ATM, including eight
single-base-pair changes and one deletion. The nucleotide positions
and the base pair changes defining the haplotypes are 378TrA,
657TrC, IVS838TrC, IVS925TrG, IVS17-56GrA, IVS24-
9delT, IVS35-68TrG, 5557GrA, IVS62-55TrC, and 12563TrG
where variation corresponding to amino acid changes is underlined.
There are 133,342 bp between the first and the last markers. Hap-
lotypes are defined as follows (the base pair change defining a new
haplotype is underlined)—H1: TTTTATTGTT; H2: TTTTGTTGTT;
H3: TTTTG(delT)TATT; H4: TTTTATTGCG; H5: ATTGATGGCG;
H6: ACTGATGGCG; H7: ATCGATGGCG.
other 23 were homozygous for different base pairs in
human and chimpanzee. Twelve variants resulted in an
amino acid change, and 20 were silent. Figure 3B shows
the distribution and frequency of coding-sequence poly-
morphisms within humans. In figures 3A and 3B, se-
quence differences that resulted in an amino acid change
are shown as black symbols, and silent base-pair changes
are shown as white symbols.
Two regions of the protein with known functional
motifs encoding the leucine zipper and kinase domains,
as well as one region with homology to the distantly
related yeast (Saccharomyces cerevisiae) Tel1p protein
are indicated by solid shading. The shaded regions rep-
resent ∼29% of the amino acid coding sequence. Of the
58 polymorphisms found in human or chimpanzee, only
3 map to the conserved regions of the protein. If poly-
morphisms are assumed to be distributed uniformly and
at random, the probability of seeing three or fewer in
the conserved region is !.01.
Nucleotide Diversity
Figure 4 shows the nucleotide diversity of 15 auto-
somal and 3 Y-chromosome genes (Shen et al. 2000)
that have been analyzed by DHPLC. Nucleotide diver-
sity was calculated from the number of differences be-
tween any two randomly chosen sequences. Given the
number of segregating sites, the nucleotide diversity of
the coding region of ATM was very low. For the 9,168-
bp coding region, the value was .40.71 0.61# 10
That is 4.5-fold less sequence diversity than the average
in 64,676 coding base pairs in 15 other autosomal genes
analyzed by DHPLC (Wagner et al. 1999a; Shen et al.
2000; Passarino et al. 2001; dbSNP Home Page; D. Cox,
C. Franco, R. Ghali, P.J. Oefner, A. Roxas, P. Shen, T.A.
Sivakumaran, R. Sung, T. Tang, F. Wong, W.-T. Yang,
unpublished data), and 7-fold less than that reported in
135,823 coding base pairs in 106 human genes (Cargill
et al. 1999).
There was a large difference between the nucleotide
diversities of ATM in the coding and noncoding regions.
Whereas most genes in the study had similar nucleotide-
diversity estimates in the protein coding and noncoding
regions, with ratios ranging from 1:2.5 to 1:1, in ATM
the ratio was 1:7.5. Since the sequence diversity was
normal in the noncoding regions compared to that in
the other genes, it is clear that there was not a generally
lower mutation rate in the chromosomal region con-
taining ATM. More likely, the lower sequence diversity
in the coding region is due to selective pressure for main-
taining the protein sequence.
Only three genes—two on the Y chromosome (SMCY
and DFFRY) and one small autosomal gene with 2,650
bp of coding sequence (the retinoblastoma gene,
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Figure 3 Distribution of coding-sequence polymorphisms in ATM and differences between chimpanzee and human. A, Location of
polymorphisms and coding-sequence differences in chimpanzee compared to human. B, Location and frequency of polymorphisms observed in
human ATM. The horizontal bar represents amino acid sequence of ATM from 1 to 3056. Colored and shaded regions of the amino acid
sequence represent possible functional domains of the molecule: p53 binding (Khanna et al. 1998), leucine zipper (Morgan et al. 1997), homology
to S. pombe Rad3p (Bentley et al. 1996) and S. cerevisiae Tel1p (Greenwell et al. 1995; Morrow et al. 1995), and the serine kinase domain
(Zakian 1995). Ball-and-stick figures along the amino acid sequence represent amino acid positions. Circles are mapped at positions that are
polymorphic either within the 93 human individuals (with the number of individuals adjacent to each circle) or within the single chimpanzee
individual; diamonds represent homozygous differences between human and chimpanzee. Black circles or diamonds represent missense poly-
morphisms, and white circles or diamonds represent silent changes.
RB1)—had less coding diversity than ATM. When ATM
and RB1 were compared more closely, it is interesting
that the last 2,650 bp (29%) of the ATM coding region
had even less sequence diversity than RB1 (p was
and , respectively.) Even4 40.0415# 10 0.076# 10
when the remaining 6,518 bp of ATM were considered
separately, the sequence diversity was ,40.965# 10
suggesting considerable constraint on the evolution of
this gene compared to other autosomal genes. Loss of
some neutral sequence diversity across the gene might
be expected during background selection, because del-
eterious mutations will eliminate variants that are linked
on the same haplotype.
When nucleotide diversity was calculated for African
and non-African populations separately, most genes
showed little difference. However, in ATM, the non-
African population had four times less sequence diver-
sity ( ) than did the African population40.437# 10
( ).41.75# 10
Statistical Analysis for the Hypothesis of Selection at
ATM
Calculation of the Tajima’s D statistic also suggested
that selection has operated on ATM. In the Tajima’s D
test, for selectively neutral mutations in a con-Dp 0
stant-population infinite-sites model, whereas inD ! 0
the case of purifying selection or in an expanding pop-
ulation (Tajima 1989a, 1989b). In an expanding-pop-
ulation model (Sherry et al. 1994; Kimmel et al. 1998;
Pritchard et al. 1999; Shen et al. 2000; Zhivotovsky et
al. 2000), all genes would be expected to behave sim-
ilarly. However, Tajima’s D value was statistically neg-
ative for only four of the autosomal genes reviewed in
the present study, including ATM. For example, for
ATM, , which was statistically significantDp 1.98
at , reflecting the overabundance of rare alleles.P ! .05
The HKA test (Hudson et al. 1987) compares the
number of intraspecies (within-human) polymorphisms
and interspecies sequence differences at different loci,
with the expectation of a model of neutral evolution.
First, the human and chimpanzee orthologs were com-
pared. The coding region of ATM had 26 polymor-
phisms in humans over 9,168 bp and had 32 differences
between humans and chimpanzee over 9,029 bp. The
combined coding regions of 11 other autosomal genes
(AMPD1, CSTB, MMP1, MMP3, MMP12, ABCB1,
BRCA2, XRCC1, FBN1, COX2, and IL-4) had 123
polymorphic sites in human over 30,996 bp and 79 dif-
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Figure 4 Nucleotide diversity in coding and noncoding regions of 15 autosomal and 3 Y-chromosome genes. Nucleotide diversity, or
heterozygosity, was calculated as described in the Subjects, Material, and Methods section. Autosomal genes are shown in black and gray, and
Y-chromosome genes are shown in red and pink.
ferences between human and chimpanzee over 22,343
bp. The HKA statistic for reduced variability in human
ATM compared to chimpanzee was not statistically sig-
nificant ( , ).2x p 0.47 Pp .49[1]
However, the HKA test would fail to detect selection
if the same selective pressures were operating in both
human and chimpanzee. To test the possibility that the
reduced variability of the last 29% of the ATM coding
sequence was due to selective pressure in both chim-
panzee and human, five cross-species comparisons were
performed (table 3). In contrast to human and chim-
panzee, there was little reduced variability in that region
in gorilla ( , ) and none in orangu-2x p 3.58 Pp .059[1]
tan, Old World monkey, or mouse ( , ).2x 1 4.7 P ! .02[1]
Thus, selective pressure appears to be operating in the
last 29% of the ATM coding region in humans, chim-
panzees, and possibly in gorilla, but not in orangutan,
Old World monkey, or mouse.
Discussion
The present study represents the first comprehensive sur-
vey of neutral variation in the ATM gene in diverse hu-
man populations. ATM is important for the regulation
of cellular responses to DNA damage, for oxidative
stress, and for the control of cell cycle checkpoints. It is
a protein kinase that phosphorylates many substrates,
including p53 tumor suppressor protein.
All of the protein-encoding exons of the gene (9,168
bp), as well as adjacent intron and untranslated se-
quences (14,661 bp), were analyzed in 1 chimpanzee
and 93 human samples. The sequences analyzed were
those that would most likely affect protein function,
either by altering amino acids in functional domains or
by affecting intron splicing. A diverse collection of 93
human genomic DNAs were chosen for analysis. To
include as much genetic diversity as possible, African
and Oceanian populations were overrepresented rela-
tive to others.
The analysis method, DHPLC, was shown to be 99%
sensitive for detection of sequence variation in the ATM
gene (data not shown.) Important technical details, such
as use of a temperature-prediction algorithm and ex-
amples of subtle chromatographic shifts, have been in-
cluded here so that others can reproduce the sensitivity
reported.
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Table 3
Comparisons of Two ATM Gene Regions with Orthologs in Five Other Species, Using the
HKA Statistic
SPECIES
NO. OF DIFFERENCES (NO. OF
BASE PAIRS ANALYZED) IN
x2 PFirst 71% of ATM Last 29% of ATM
Chimpanzee 21 (6518) 2 (2650) .157 .692
Gorilla 28 (5341) 7 (1855) 3.58 .059
Orangutan 42 (4795) 19 (2308) 5.02 .025a
Old World Monkey 68 (3364) 28 (1406) 5.38 .020a
Mouse 970 (6518) 349 (2650) 4.72 .030a
a Statistically significant.
Sequence Diversity in ATM
A total of 88 different polymorphic sites were dis-
covered in human ATM, and 23 homozygous differences
were found between human and chimpanzee in the cod-
ing region. The chimpanzee was heterozygous (poly-
morphic) at nine additional sites. Only one human sam-
ple, from an African, had as many heterozygous sites,
consistent with a report elsewhere that chimpanzee pop-
ulations have greater genetic diversity than do human
populations (Kaessmann et al. 1999).
Most of the ATM polymorphisms were relatively rare,
leading to a low overall sequence diversity. The high
number of rare variants contributed to the generation
of a significantly negative value for Tajima’s D statistic.
Such an effect can occur for a rapidly expanding pop-
ulation. However, the number of rare variants in ATM
was higher than the average seen in 14 other autosomal
genes, suggesting that other forces were operating. For
example, purifying selection would cause this effect by
eliminating variation linked to deleterious mutations.
The low sequence diversity in the coding region of
ATM was noteworthy, because it encodes a very large
(350 kDa) protein that may be able to tolerate many
amino acid changes. However, ATM was the second-
least variable of the autosomal genes analyzed. The only
autosomal gene with less coding-sequence diversity was
RB1. Interestingly, both ATM and RB1 have functions
in cell-cycle control (Mulligan and Jacks 1998; Lavin
1999) and therefore may have similar constraints on
their evolution.
The overall diversity of ATM was comparable to that
of three genes on the Y chromosome. The Y chromo-
some has previously been shown to have less diversity
than autosomal genes, mostly because of its fourfold
smaller effective population size (Jobling and Tyler-
Smith 1995; Nachman 1998), but also because of the
possible action of sexual selection (Wyckoff et al. 2000)
and demographic factors, such as polygamy (Shen et al.
2000).
Haplotype Analysis
Of 17 common markers in ATM, 10 showed no ev-
idence of recurrent mutation and were in complete link-
age disequilibrium with each other over 1133 kb. Pre-
vious reports have also demonstrated extensive linkage
disequilibrium at ATM (Gatti 1998; Li et al. 1999; Bon-
nen et al. 2000), and in other regions of the genome
(Collins et al. 1999; Huttley et al. 1999; Gordon et al.
2000; Taillon-Miller et al. 2000). Interestingly, the rate
of recombination appears to be the same in patients with
A-T and in unaffected individuals (Lange et al. 1995).
Through use of haplotypes defined by the 10 markers
that were completely linked, it was possible to construct
a parsimonious phylogeny (fig. 4). Because the mutation
rate of single-nucleotide changes is much lower than that
of nucleotide repeats, the resulting phylogeny is older
than one derived from microsatellite markers.
A previous study (Bonnen et al. 2000) identified hap-
lotypes at ATM, using SNP markers that were identified
only in noncoding sequence. Different regions of the
ATM gene were analyzed in the two studies, with ∼25%
overlap in sequence. Consequently, only two markers,
IVS22-77TrC and IVS62-55TrC, were found by both
groups. In the present study, IVS22-77TrCwas not used
in the definition of haplotypes, because it was recurrent
in three samples. The genotypes of a third marker that
was common in the population, 10182TrA, were de-
termined in this set of samples.
The observed number and global distribution of hap-
lotypes in ATM were comparable to those reported ear-
lier (Bonnen et al. 2000). Both studies observed that a
small number of haplotypes represented the vast ma-
jority of chromosomes analyzed, with 2 of 7 haplotypes
representing 82% of chromosomes (present study) and
6 of 22 haplotypes representing 89% of chromosomes
(Bonnen et al. 2000). Some of the haplotypes in the two
studies may be identical. For example, three missense
polymorphisms were associated with unique haplotypes
in the two studies: S49Cwas found on haplotype 2 (Bon-
nen et al. 2000) and on H4 (this study), P1054R was
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found on haplotype 17 and on H2, and D1853N was
found on haplotype 15 and on H3.
Implications for Identification of Neutral Variation
Our observations of DNA sequence variation in the
human ATM gene have important implications for dis-
tinguishing between neutral variants and functional mu-
tations. For example, all of the 88 variants reported here
are likely to be neutral, unless one or two individuals
are among the 1%–2% of the population that are car-
riers of ATM mutations (Gatti et al. 1999; Li and Swift
2000). Functional mutations in carriers may exist either
in protein-coding DNA or in noncoding DNA associated
with splicing. Four intron variants near splice-donor or
-acceptor sites were compared with splice consensus se-
quences, using an algorithm available at the Berkeley
Drosophila Genome Project Web site. None of them sig-
nificantly altered the splice consensus score, although
analysis of RNA may be necessary to further clarify this
issue. One variant associated with breast cancer, IVS10-
6TrG (Broeks et al. 2000), and one missense polymor-
phism common in the German population, 2119TrC
(“S707R” in the report by Do¨rk et al. [1997]), were not
detected in our cohort.
Additional general conclusions about neutral varia-
tion in ATM can be drawn. The significantly negative
value of Tajima’s D statistic, as well as the low nucle-
otide diversity in the protein-coding region, suggest that
ATM is under an unusual degree of evolutionary con-
straint. Whereas the diversity in the coding sequencewas
very low, the diversity of noncoding sequence was com-
parable to that in other genes, indicating that the lack
of diversity was not caused by a generally lower mu-
tation rate at the ATM locus.
Not surprisingly, the smallest amount of sequence di-
versity was found in conserved regions that have putative
functional domains. For example, there was only a single
sample with a single variant in the entire carboxy-ter-
minal 29% of the amino acid sequence, corresponding
to the kinase and Tel1p homology domains. This region
of ATM was significantly less diverse in human and
chimpanzee than it was in orangutan, Old World mon-
key, and mouse. Consequently, either a selective pressure
operates only in the former group or the selective pres-
sures in the two groups are different because of divergent
roles for the ATM protein in the different species.
Intriguingly, the functional constraint inATMmay not
be restricted to the amino acid sequence. The reduced
number of silent mutations in the 3′ noncoding region
of the gene suggests that this region may contain se-
quences that regulate mRNA stability or splicing. For
example, the smallest exon in the gene, exon 63, is !100
bp in length and has a splice-acceptor site with a very
weak homology to known splice donor consensus se-
quences. Efficient splicing at such exons is likely to re-
quire splicing enhancers (Carlo et al. 1996; Cooper and
Mattox 1997).
Differences in ATM between African and Non-African
Populations
In addition to the low overall sequence diversity in
ATM compared to other human genes, there were strik-
ing differences between African and non-African pop-
ulations. For example, the sequence diversity of ATM in
Africa was fourfold greater than it was outside of Africa.
One reason for this difference was the presence of three
frequent polymorphisms that defined theAfrican-specific
haplotypes H6 and H7. H6 was concentrated in central
Africa, but H7 was found all across the continent.
Only two common amino acid substitutions were ob-
served in the global population, and they were both rel-
atively conservative changes (DrN and DrE). The
D1856N variant was relatively common in non-Africans
and was not found in Africans. In contrast, the D126E
variant was very common in Africans but was extremely
rare in non-Africans. Because the divergent ATM pro-
teins were geographically isolated from one another, it
is possible that the polymorphisms arose and were prop-
agated by random genetic drift after the migration of
humans out of Africa. TheD126E variantmay have been
propagated with haplotype H7 in the Bantu expansion
within Africa (Cavalli-Sforza 1994), in a situation anal-
ogous to that of markers M40 andM96 in the published
Y-chromosome phylogeny (Underhill et al. 2000).
It is also possible, however, that the high allele fre-
quency of D126E in Africa and its absence elsewhere is
due to selective pressure. The presence of an allele that
has reached equilibrium in one human population yet
is not found elsewhere in the world is very unusual (Hal-
ushka et al. 1999); the overwhelming majority of alleles
that are common in Africa are also common elsewhere
(Zietkiewicz et al. 1997; Tishkoff et al. 1998). High
heterozygosity for a locus might be caused by balancing
selection in an area where the presence of two different
alleles is advantageous, as is the case with sickle-cell
anemia (MIM 603903). Although the proportion of in-
dividuals with the genotypes D/D, D/E, and E/E was
consistent with Hardy-Weinberg expectations, the num-
ber of individuals analyzed here was too small to rule
out selective pressure.
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